Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients
Titel:
Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients
Auteur:
Foy, Jean-Philippe Karabajakian, Andy Ortiz-Cuaran, Sandra Boussageon, Maxime Michon, Lucas Bouaoud, Jebrane Fekiri, Dorssafe Robert, Marie Baffert, Kim-Arthur Hervé, Geneviève Quilhot, Pauline Attignon, Valéry Girod, Angélique Chaine, André Benassarou, Mourad Zrounba, Philippe Caux, Christophe Ghiringhelli, François Lantuejoul, Sylvie Crozes, Carole Brochériou, Isabelle Pérol, Maurice Fayette, Jérôme Bertolus, Chloé Saintigny, Pierre